{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/how-can-ai-ophthalmology-transform-each-critical-stage-your-trial-journey#webpage",
"url": "https://www.fortrea.com/insights/how-can-ai-ophthalmology-transform-each-critical-stage-your-trial-journey",
"name": "How can AI in ophthalmology transform each critical stage of your trial journey?",
"description": "Explore this Fortrea white paper on AI in ophthalmology clinical trials and discover how artificial intelligence and machine learning are transforming modern ophthalmic research through advanced ocular imaging analytics, predictive patient identification, and AI-powered operational strategies. The white paper highlights how AI-driven clinical development improves patient recruitment efficiency, reduces screen failure rates, enhances ophthalmology trial optimization, and supports data-driven decision-making across complex ophthalmic studies. Learn how retinal image analytics, predictive analytics, intelligent clinical workflows, and automated operational models are helping sponsors accelerate innovation, improve study scalability, strengthen data quality, optimize site selection, and enable more efficient, patient-centric ophthalmology clinical trial execution across the development lifecycle."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "How can AI in ophthalmology transform each critical stage of your trial journey?",
"item": "https://www.fortrea.com/insights/how-can-ai-ophthalmology-transform-each-critical-stage-your-trial-journey"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/how-can-ai-ophthalmology-transform-each-critical-stage-your-trial-journey#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/how-can-ai-ophthalmology-transform-each-critical-stage-your-trial-journey#webpage"
},
"headline": "AI in Ophthalmology Clinical Trials & Machine Learning-Driven Trial Optimization | Fortrea White Paper",
"description": "Explore this Fortrea white paper on AI in ophthalmology clinical trials and discover how artificial intelligence and machine learning are transforming modern ophthalmic research through advanced ocular imaging analytics, predictive patient identification, and AI-powered operational strategies. The white paper highlights how AI-driven clinical development improves patient recruitment efficiency, reduces screen failure rates, enhances ophthalmology trial optimization, and supports data-driven decision-making across complex ophthalmic studies. Learn how retinal image analytics, predictive analytics, intelligent clinical workflows, and automated operational models are helping sponsors accelerate innovation, improve study scalability, strengthen data quality, optimize site selection, and enable more efficient, patient-centric ophthalmology clinical trial execution across the development lifecycle.",
"genre": "White Paper",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-09/ai-ophthalmology-trials-every-stage.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-09-10",
"dateModified": "2025-09-10",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-03/fortrea-ai-ophthalmology-clinical-trials-whitepaper_0.pdf",
"encodingFormat": "application/pdf"
}
}
]
}